Fund moves
94 tracked managers disclosed the same change for Q1 2026. From a 13F filed Aug 26, 2026 covering holdings at Mar 31, 2026 — a quarter-end snapshot, not a live trade.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Aug 14, 2026 · Filed Aug 18, 2026
AbbVie's CHIEF BUS/STRAT OFFICER sold $8.18M of AbbVie shares. The filing does not indicate a pre-arranged trading plan.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
open market sale
Code S — open-market or private sale
~$8,177,500
Shares × reported transaction price
14 days after results of Jul 31, 2026, 52 days before results of Oct 5, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $249.46 on Aug 14, 2026, 26% above its 52-week low and 5% below its high, after a 4% drop over the previous 30 trading days
52-week range $197.38 (Apr 27, 2026) to $263.30 (Jul 29, 2026), 79% of the way up, from 251 adjusted closes. 30 trading days earlier: $261.07 on Jul 2, 2026. Describes the past only, not a forecast
None found in footnotes
Only flagged when a footnote says so; never inferred
Nicholas Donoghoe's largest sale of ABBV in their filings since 2023
Compared with every open-market purchase and sale of this company in SEC filings since 2006. A fact about the record, not a signal to trade
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | −1.1% | −0.4% | −0.8% |
| 30 days | −0.8% | −1.0% | +0.2% |
| 90 days | +10.1% | −4.8% | +14.9% |
Past results only. Not a forecast.
Fund moves
94 tracked managers disclosed the same change for Q1 2026. From a 13F filed Aug 26, 2026 covering holdings at Mar 31, 2026 — a quarter-end snapshot, not a live trade.
Fund moves
122 tracked managers disclosed the same change for Q2 2026. From a 13F filed Aug 25, 2026 covering holdings at Jun 30, 2026 — a quarter-end snapshot, not a live trade.
Insider filing
Traded Aug 14 · filed 4 days later
Derivative exercise or conversion — not an open-market buy.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.